Director, Obesity Early Pipeline Commercial Development

• Own end-to-end commercial assessments for a portfolio of early- and mid-stage obesity assets across multiple mechanisms and development stages
• Build product concepts and Target Product Profiles and develop disease-area strategies
• Shape early development strategy in partnership with clinical and research colleagues
• Interpret business unit and obesity franchise strategy to establish program priorities and direction
• Integrate forecasting, pricing, HCP demand, future landscaping, and patient-flow modeling into commercial plans
• Support core global asset deliverables aligned with clinical profile, customer insights, and competitive positioning
• Monitor external market, competitive, and policy developments and adapt asset strategies
• Evaluate lifecycle management and expansion opportunities and develop business cases and scenario analyses
• Support business development evaluations and due diligence
• Lead strategic initiatives across the broader obesity portfolio, including emerging access models
• Advance assets through enterprise governance milestones and prepare governance materials
• Present asset-level and portfolio strategy and investment cases to senior leadership
• Mobilize cross-functional resources and manage consultants or agency partners as needed
• Champion innovation, appropriate risk-taking, and knowledge sharing across the commercial development organization

• BA/BS required
• Minimum 8 years of pharmaceutical, biotechnology, healthcare, or related industry experience
• Experience in commercial development, new product planning, marketing, portfolio strategy, or related strategy roles
• Proven experience leveraging AI to enhance work deliverables and speed of delivery
• Knowledge of obesity, cardiometabolic, or related therapeutic areas
• Familiarity with the pharmaceutical development process
• Familiarity with the regulatory process for drug approvals
• Demonstrated ability to execute effectively in highly dynamic and evolving markets
• Strong analytical skills
• Ability to communicate complex information clearly and succinctly
• Advanced degree (MBA, PharmD, PhD, MD, MPH, or equivalent) preferred
• Advanced scientific and business acumen with experience in obesity or metabolic disease preferred
• Experience supporting early-stage development assets and development strategy preferred
• Experience collaborating with R&D and Commercial cross-functional partners preferred
• Experience with market research execution preferred
• Experience developing forecasts, asset valuations, business cases, and scenario analyses preferred
• Experience supporting business development assessments or due diligence preferred
• Experience preparing and presenting strategic recommendations to senior leadership or governance forums preferred
• Demonstrated ability to lead and influence cross-functional teams without direct line authority preferred
• Ability to analyze complex clinical, commercial, and financial data sets and translate findings into strategic recommendations
• Ability to manage multiple priorities, changing business needs, and significant ambiguity
• Ability to participate in extended strategic planning, governance, and operational review meetings
• Domestic and international travel up to approximately 10–20%
• Must be authorized to be employed in the U.S. by any employer
• U.S. work visa sponsorship is not available now or in the future
• Requires permanent work authorization in the United States

Demonstrates expertise in commercial development and strategic planning within the pharmaceutical and biotechnology sectors, particularly in obesity and cardiometabolic therapeutic areas. Proven ability to lead cross-functional teams, analyze complex data, and present strategic recommendations to senior leadership.

• Commercial Development
• Obesity Therapeutic Knowledge
• Strategic Planning
• Cross-Functional Collaboration
• Market Research Execution

• New Product Planning
• Forecast Development
• Business Case Development
• Scenario Analysis
• Regulatory Process Familiarity
• AI Utilization
• Analytical Skills
• Asset Valuation
• Lifecycle Management
• Competitive Positioning

• Effective Communication
• Leadership
• Adaptability
• Risk-Taking
• Knowledge Sharing

• BA/BS
• MBA
• PharmD
• PhD
• MD
• MPH

• Pharmaceutical
• Biotechnology
• Healthcare
• Obesity
• Cardiometabolic
• Commercial Strategy
• Governance
• Market Dynamics
• HCP Demand
• Patient-Flow Modeling